KIMBERLY SCHULTZ: Open Payments
NPI 1962453910 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 4 payments from 4 companies in 2025. Trend: 2023 $153 · 2024 $231 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $145 |
| Ipsen Biopharmaceuticals, Inc | 1 | $120 |
| Janssen Biotech, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
Products named: DAXXIFY, IQIRVO, TREMFYA.
Industry payments across NE — which companies pay providers there.
